The Clinical Trial Application (CTA) approval clears the way for the company to launch trial locations in France and Romania
ENFLONSIA is a long-acting monoclonal antibody designed to shield infants through a typical five-month RSV season with a single, fixed dose
The collaboration combines Takara Bio’s large-scale testing technology with Resistomap’s data-driven AMR intelligence
Consensus calls for nationwide adoption of potassium-enriched salt to reduce cardiovascular disease risk
Advisory from Apollo Spectra Hospitals highlights hydration, nutrition, and screening as key preventive measures
The company allocated €56 million to research and development for next-generation line solutions
Integrated eCOA technology and rater training aim to reduce variability and strengthen ClinRO outcomes
The study evaluated asundexian (50 mg), a once-daily oral anticoagulant candidate, versus placebo—both given alongside standard antiplatelet therapy
he innovation could pave the way for early and low-cost screening of smoking exposure and second-hand smoke biomarkers
Outlines nine priority health tracks spanning TB research, digital health, early warning systems and regulatory cooperation
Subscribe To Our Newsletter & Stay Updated
